Correlation Between Beam Therapeutics and Repligen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Beam Therapeutics and Repligen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beam Therapeutics and Repligen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beam Therapeutics and Repligen, you can compare the effects of market volatilities on Beam Therapeutics and Repligen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beam Therapeutics with a short position of Repligen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beam Therapeutics and Repligen.

Diversification Opportunities for Beam Therapeutics and Repligen

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between Beam and Repligen is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Beam Therapeutics and Repligen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Repligen and Beam Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beam Therapeutics are associated (or correlated) with Repligen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Repligen has no effect on the direction of Beam Therapeutics i.e., Beam Therapeutics and Repligen go up and down completely randomly.

Pair Corralation between Beam Therapeutics and Repligen

Given the investment horizon of 90 days Beam Therapeutics is expected to under-perform the Repligen. In addition to that, Beam Therapeutics is 1.39 times more volatile than Repligen. It trades about -0.03 of its total potential returns per unit of risk. Repligen is currently generating about -0.02 per unit of volatility. If you would invest  14,381  in Repligen on December 29, 2024 and sell it today you would lose (1,040) from holding Repligen or give up 7.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Beam Therapeutics  vs.  Repligen

 Performance 
       Timeline  
Beam Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Beam Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Repligen 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Repligen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Repligen is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Beam Therapeutics and Repligen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Beam Therapeutics and Repligen

The main advantage of trading using opposite Beam Therapeutics and Repligen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beam Therapeutics position performs unexpectedly, Repligen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will offset losses from the drop in Repligen's long position.
The idea behind Beam Therapeutics and Repligen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing